Information Library
Case Studies - Enrollment & retention
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Hepatitis B Vaccine-Successful Study Strategy in Asia
November 9, 2009
Quintiles helped a customer overcome recruitment and regulatory challenges for a Hepatitis B vaccine study in Asia. -
Nasal Influenza Vaccine
September 22, 2009
Quintiles helped a customer overcome recruitment and regulatory challenges for a nasal influenza vaccine study in Argentina, Brazil and South Africa. -
Diabetes Outcomes
September 8, 2009
This Phase IIIB diabetes study involved cardiovascular outcomes assessed over 6 years. Learn how Quintiles helped the customer overcome the challenges of patient retention, data collection and evaluation. -
Post-Marketing Commitment Study
June 30, 2009
Quintiles developed creative and effective solutions to deliver quality data, cost efficiently and ahead of schedule. -
Strong Site Relationships Support Rapid Recruitment
March 27, 2009
To conduct a worldwide oncology registration study, a top 10 pharmaceutical company came to a unit of Quintiles in Europe that focuses exclusively on oncology studies. Not only does the department head have 14 years of experience in cancer clinical research, but her 13 project managers were chosen specifically because of their extensive knowledge of how to run global cancer studies. -
Cardiovascular Expertise Results in Faster Enrollment Speed
March 27, 2009
Mega-trials require mega-expertise, especially when the global study is for an innovative cardiovascular drug to treat patients with acute coronary syndrome who have also undergone coronary artery bypass surgery. -
Antibiotic Safety Assessment
March 25, 2009
A major pharmaceutical company presented Quintiles with a pressing challenge – to collect extensive amounts of Phase IV data in compressed time windows because the treatment conditions were subject to seasonal variants.
Page 1 of 1 (7 items)